KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Operations: 2017-2025

Historic Cash from Operations for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$35.4 million.

  • Guardant Health's Cash from Operations rose 30.64% to -$35.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.9 million, marking a year-over-year increase of 12.27%. This contributed to the annual value of -$239.9 million for FY2024, which is 26.19% up from last year.
  • Guardant Health's Cash from Operations amounted to -$35.4 million in Q3 2025, which was up 41.26% from -$60.3 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash from Operations registered a high of -$16.3 million during Q1 2021, and its lowest value of -$111.9 million during Q2 2022.
  • In the last 3 years, Guardant Health's Cash from Operations had a median value of -$64.5 million in 2024 and averaged -$65.7 million.
  • As far as peak fluctuations go, Guardant Health's Cash from Operations tumbled by 559.61% in 2021, and later soared by 59.32% in 2024.
  • Guardant Health's Cash from Operations (Quarterly) stood at -$77.0 million in 2021, then declined by 17.87% to -$90.7 million in 2022, then grew by 13.25% to -$78.7 million in 2023, then grew by 18.06% to -$64.5 million in 2024, then surged by 30.64% to -$35.4 million in 2025.
  • Its Cash from Operations stands at -$35.4 million for Q3 2025, versus -$60.3 million for Q2 2025 and -$62.7 million for Q1 2025.